CAS: 107-83-5; 2-Methylpentane

上下游产品

CAS号108-10-1 甲基异丁基甲酮 | CAS号96-37-7 甲基环戊烷 | CAS号763-29-1 2-甲基-1-戊烯 | CAS号110-54-3 正己烷 | CAS号201230-82-2 carbon monoxide | CAS号4553-62-2 2-甲基戊二腈 | CAS号109-66-0 正戊烷 | CAS号691-37-2 4-甲基-1-戊烯 | CAS号67-56-1 甲醇 | CAS号565-69-5 2-甲基-3-戊酮 | CAS号108-10-1 甲基异丁基甲酮 | CAS号355-04-4 2-三氟甲基-1,1,1,2,... | CAS号355-42-0 全氟己烷 | CAS号865-71-4 1,1,1,2,2,3,4,4... | CAS号1805-22-7 全氟甲基环戊烷 | CAS号112156-74-8 1,1,1,2,2,4,4,4... | CAS号108-08-7 2,4-二甲基戊烷 | CAS号591-76-4 2-甲基已烷(异庚烷) | CAS号565-59-3 2,3-二甲基戊烷

4-甲基-1-戊烯置于10 Wt% Platinum On Carbon,氢气体系中,30.0 °C,400.01 Kpa 条件下,反应生成2-甲基戊烷
参考文献:Molecular Sieving Carbon Catalysts For Liquid Phase Reactions: Study Of Alkene Hydrogenation Using Platinum Embedded Nanoporous Carbon
标题:Molecular Sieving Carbon Catalysts For Liquid Phase Reactions: Study Of Alkene Hydrogenation Using Platinum Embedded Nanoporous Carbon
摘要:We Present A Simple Method To Synthesize Shape Selective Carbon Catalysts For Large Alkene Hydrogenation Reactions By Tailoring Porosity Of Platinum Embedded In Polyfurfuryl Alcohol Derived Carbons. A Small Amount Of Mesoporosity,In Addition To The Intrinsic Microporous Nature Of The Carbon,Shortens The Diffusion Length For The Reactant Molecule,Enabling These Materials To Be Used For Catalysis In The Liquid Phase. A Systematic Study Of Hydrogenation Reactions Of Liquid Phase Alkenes Is Reported. The Molecular Sieving Effect Of The Catalyst Was Examined By Varying Molecular Length,Size,Double Bond Position,Stereoregularity And The Number Of Double Bonds In The Alkenes. (C) 2012 Elsevier B.V. All Rights Reserved.
Doi:10.1016/j.Molcata.2012.10.026

专利信息

专利号:US-11926589-B2
优先权日:2019-07-09
标 题 :Process for the synthesis of non-racemic cyclohexenes
发明人：REISMAN SARAH; ROMBOLA MICHAEL; LADD CAROLYN L; MCLAUGHLIN MARTIN JOHN; ZUEND STEPHAN; GOETZ ROLAND
权利人:BASF CORP; CALIFORNIA INST OF TECHN
摘要:This invention relates to a process for the synthesis of a non-racemic cyclohexene compound of formula (I) by a Diels-Alder reaction of a compound of formula (II) with a compound of formula (III) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and Y have the meanings as defined in the description in the presence of a catalyst comprising at least one m-valent metal cation M m+ wherein the metal M is selected from Scandium (Sc), Yttrium (Y), Lanthanum (La), Cerium (Ce), Praseodymium (Pr), Neodymium (Nd), Promethium (Pm), Samarium (Sm), Europium (Eu), Gadolinium 15 (Gd), Terbium (Tb), Dysprosium (Dy), Holmium (Ho), Erbium (Er), Thulium (Tm), Ytterbium (Yb), Lutetium (Lu), Gallium (Ga) and Indium (In), and m is an integer of 1, 2 or 3, and a chiral ligand of the formula (IV) wherein R 10a , R 10b , R 10c , R 10d , R 10a′ , R 10b′ , R 10c′ , R 10d′ , Z and Z′ have the meanings as defined in the description.

专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人：GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-2021107859-A1
优先权日:2018-04-06
标题 :A process for the synthesis of carbon labeled organic compounds
发明人：AUDISIO DAVIDE; CANTAT THIBAULT; DESTRO GIANLUCA
权利人:COMMISSARIAT ENERGIE ATOMIQUE
摘要:A process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group is described. A method of using carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; a process for manufacturing labeled pharmaceuticals and agrochemicals comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure; and a process for producing tracers comprising synthesis of carbon labeled organic compounds containing a carbon labeled carboxyl group according to the present disclosure are also described.

专利号:US-7973171-B2
优先权日:2005-06-13
标题:Process for synthesis of dialkoxyorganoboranes
发明人：BURKHARDT ELIZABETH; ATKINS WILLIAM
权利人:BURKHARDT ELIZABETH; ATKINS WILLIAM
摘要:The invention relates to a process for the synthesis of dialkoxyorganoboranes, in particular to a process for the synthesis of dialkoxyorganoboranes by an ester exchange reaction. Moreover, the invention relates to a process for the synthesis of organo-oxazaborolidine catalysts (organo-CBS) and of trialkylboroxins. Furthermore, the invention relates to methods of using dialkoxyorganoboranes for the preparation of organo-CBS catalysts and in Suzuki-type coupling reactions.

专利号:US-9126995-B2
优先权日:2011-11-08
标题:Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound
发明人：TOYAMA KEN-ICHI; MORIYAMA YUJI; MATOBA KAZUTAKA; YAOSAKA MANABU; IKEDA EITATSU
权利人:NISSAN CHEMICAL IND LTD
摘要:There is provided a method for catalytic asymmetric synthesis of optically active isoxazoline compound and an optically active isoxazoline compound. A method for catalytic asymmetric synthesis of optically active isoxazoline compound of a formula (6) including reacting an α,β-unsaturated carbonyl compound of a formula (1) and a hydroxylamine in a solvent in the presence of a base by adding a chiral phase transfer catalyst. An optically active isoxazoline compound of a formula (13) that can be synthesized by the method.

专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人：DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.